SCIO-469 and bortezomib

DRUG2 trials

Sponsors

Scios, Inc.

Conditions

Multiple Myeloma

Phase 2

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

CompletedNCT00087867

Scios, Inc.Multiple Myeloma

Start: 2004-06-30End: 2005-09-30Updated: 2010-10-18

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

CompletedNCT00095680

Scios, Inc.Multiple Myeloma

Start: 2004-11-30End: 2006-02-28Updated: 2010-10-22